| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.69 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.13 | 0.004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.004 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |